Simplicity Wealth LLC Has $5.95 Million Stake in UnitedHealth Group Incorporated $UNH

Simplicity Wealth LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 141.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,077 shares of the healthcare conglomerate’s stock after buying an additional 11,179 shares during the quarter. Simplicity Wealth LLC’s holdings in UnitedHealth Group were worth $5,952,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of UNH. Nuveen LLC acquired a new stake in shares of UnitedHealth Group during the first quarter worth about $3,846,764,000. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP raised its position in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. National Bank of Canada FI raised its position in UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after buying an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after buying an additional 847,054 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. KeyCorp dropped their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Robert W. Baird restated an “underperform” rating and issued a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $360.17 on Friday. The stock has a 50 day moving average of $307.84 and a 200-day moving average of $354.55. The company has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.